MAPS vs SKIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

MAPS

61.2
AI Score
VS
MAPS Wins

SKIN

38.5
AI Score

Investment Advisor Scores

MAPS

61score
Recommendation
BUY

SKIN

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MAPS SKIN Winner
Revenue 124.49M 206.19M SKIN
Net Income -970,000 -10.19M MAPS
Net Margin -0.8% -4.9% MAPS
Operating Income -3.81M 6.75M SKIN
ROE -1.6% -18.3% MAPS
ROA -0.5% -2.6% MAPS
Total Assets 177.97M 389.06M SKIN
Current Ratio 2.97 2.89 MAPS

Relative Price Performance (Last 90 Days)

MAPS 1M: -40.8% · 3M: -55.2% SKIN 1M: +2915.2% · 3M: +2369.7%

Current Technical Phase

MAPS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.6%), weak momentum, RSI 34

RSI (14): 34.0 · Price: $0.37

SKIN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (510.6% over 20 days), RSI 78

RSI (14): 78.3 · Price: $16.30

Fundamentals Snapshot

Metric MAPS SKIN
Market Cap — —
Forward P/E 2.8 4.2
Trailing P/E 20.4 —
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.9% 0.7%
Operating Margin 0.2% 0.1%
EPS 0.02 -2.98
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MAPS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.